BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28858899)

  • 1. Patients Undergoing Cesarean Delivery After Exposure to Oxytocin During Labor Require Higher Postpartum Oxytocin Doses.
    Foley A; Gunter A; Nunes KJ; Shahul S; Scavone BM
    Anesth Analg; 2018 Mar; 126(3):920-924. PubMed ID: 28858899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study.
    Lavoie A; McCarthy RJ; Wong CA
    Anesth Analg; 2015 Jul; 121(1):159-164. PubMed ID: 25902327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes after institution of a new oxytocin infusion protocol during the third stage of labor and immediate postpartum period.
    Dagraca J; Malladi V; Nunes K; Scavone B
    Int J Obstet Anesth; 2013 Jul; 22(3):194-9. PubMed ID: 23692707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F; Treisser A; Comparetto C
    Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbetocin at Cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose.
    Nguyen-Lu N; Carvalho JC; Farine D; Seaward G; Ye XY; Balki M
    Can J Anaesth; 2015 Aug; 62(8):866-74. PubMed ID: 25860126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.
    Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP
    Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Dose Compared With Standard-Dose Oxytocin Regimens to Augment Labor in Nulliparous Women: A Randomized Controlled Trial.
    Son M; Roy A; Stetson BT; Grady NT; Vanecko MC; Bond N; Swanson K; Grobman WA; Miller ES; Peaceman AM
    Obstet Gynecol; 2021 Jun; 137(6):991-998. PubMed ID: 33957657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin at Elective Cesarean Delivery: A Dose-Finding Study in Pregnant People With Twin Pregnancy.
    Peska E; Balki M; Pfeifer W; Maxwell C; Ye XY; Downey K; Carvalho JCA
    Anesth Analg; 2024 Apr; 138(4):814-820. PubMed ID: 36480452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a third stage of labor oxytocin protocol on cesarean delivery outcomes.
    Lee AI; Wong CA; Healy L; Toledo P
    Int J Obstet Anesth; 2014 Feb; 23(1):18-22. PubMed ID: 24332518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.
    Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ
    Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
    George RB; McKeen D; Chaplin AC; McLeod L
    Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.
    Bischoff K; Nothacker M; Lehane C; Lang B; Meerpohl J; Schmucker C
    BMC Pregnancy Childbirth; 2017 Nov; 17(1):399. PubMed ID: 29187156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin requirements at elective cesarean delivery: a dose-finding study.
    Carvalho JC; Balki M; Kingdom J; Windrim R
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1005-10. PubMed ID: 15516392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an oxytocin protocol on secondary uterotonic use in patients undergoing Cesarean delivery.
    Davis PR; Sviggum HP; Arendt KW; Pompeian RJ; Kurian C; Torbenson VE; Hanson AC; Schulte PJ; Hamilton KD; Sharpe EE
    Can J Anaesth; 2023 Jul; 70(7):1194-1201. PubMed ID: 37280454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between the time from oxytocin cessation during labour to Cesarean delivery and postpartum blood loss: a retrospective cohort study.
    Tran G; Kanczuk M; Balki M
    Can J Anaesth; 2017 Aug; 64(8):820-827. PubMed ID: 28421545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin at elective caesarean delivery: a dose-finding study in women with obesity.
    Peska E; Balki M; Maxwell C; Ye XY; Downey K; Carvalho JCA
    Anaesthesia; 2021 Jul; 76(7):918-923. PubMed ID: 33227150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin infusion rates for maintaining uterine tone during non-elective cesarean section in laboring patients: a randomized, controlled trial.
    Mohta M; Siddiqui S; Chilkoti GT; Agarwal R
    J Anesth; 2022 Aug; 36(4):456-463. PubMed ID: 35484429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
    Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC
    Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ED
    Qian XW; Drzymalski DM; Lv CC; Guo FH; Wang LY; Chen XZ
    BMC Pregnancy Childbirth; 2019 Dec; 20(1):6. PubMed ID: 31892352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
    Vimala N; Mittal S; Kumar S
    Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.